Press Releases

Investor Resources
Contact Us
Investor ResourcesPress Releases

Press Releases

Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity’s 45th Annual Growth Conference


August 11, 2025

Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx™ in Acute Myocarditis


August 6, 2025

Cardiol Therapeutics Announces Database Lock for Phase II ARCHER Trial of CardiolRx™ in Acute Myocarditis


July 22, 2025

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders


May 29, 2025

Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT


May 27, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to its Board of Directors


April 29, 2025

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis


April 16, 2025

Cardiol Therapeutics Announces Year-End 2024 Update on Operations


April 1, 2025

Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference


March 3, 2025

2025 Cardiol Therapeutics. All right reserved.